BioSpace News Archive

Drug Development

Hemispherx Biopharma Announces New Publication Enlarges The Understanding Of Ampligen® Safety Profile Across Diverse Animal Species And Focuses On The Unique TLR-3 Receptor/Ampligen(R) Interaction

April 8, 2014
·
1 min read
Drug Development

Capstone Therapeutics Announces Initiation Of Dosing For AEM-28 Phase 1 Human Clinical Trial In LDL/Non-HDL Cholesterol Reduction

April 8, 2014
·
1 min read
FDA

Abiomed Receives CE Mark For Impella RP

April 8, 2014
·
1 min read
Business

Rich Pharmaceuticals Appoints Renping Zhou, Ph.D., To Medical Advisory Board

April 8, 2014
·
1 min read
Business

Epic Sciences Appoints Pascal Bamford, Ph.D. As Vice President Of Product Development

April 8, 2014
·
3 min read
Drug Development

Immunomedics, Inc. Reports Preclinical Results On SN-38 Antibody-Drug Conjugates As A Potential Novel Platform For Treating Cancer

April 8, 2014
·
1 min read
Business

Charles River Laboratories (Massachusetts) Schedules First-Quarter 2014 Earnings Release And Conference Call

April 8, 2014
·
1 min read
Biotech Bay

BioTime To Present At 13th Annual Needham Healthcare Conference

April 8, 2014
·
1 min read
Drug Development

Merrimack Pharmaceuticals Inc. Announces Preliminary Data From Pilot Diagnostic Imaging Study Of MM-398

April 8, 2014
·
1 min read
Drug Development

Sunesis Pharmaceuticals, Inc. Announces Presentation Of Positive Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS

April 8, 2014
·
1 min read